Raymond James & Associates Nuvasive Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$36.71 - $44.15 $47,282 - $56,865	1,288 Added 3.88%	34,470 $1.43 Million
Q1 2023 Apr 14, 2023	BUY	$36.81 - $48.12 $101,153 - $132,233	2,748 Added 9.03%	33,182 $1.37 Million
Q4 2022 Feb 08, 2023	BUY	$35.68 - $44.71 $18,981 - $23,785	532 Added 1.78%	30,434 $1.26 Million
Q3 2022 Oct 25, 2022	SELL	$42.51 - $54.02 $144,321 - $183,397	-3,395 Reduced 10.2%	29,902 $1.31 Million
Q2 2022 Aug 12, 2022	BUY	$46.84 - $59.75 $303,242 - $386,821	6,474 Added 24.14%	33,297 $1.64 Million
Q1 2022 May 11, 2022	BUY	$48.09 - $57.79 $105,076 - $126,271	2,185 Added 8.87%	26,823 $1.52 Million
Q4 2021 Feb 08, 2022	SELL	$47.19 - $62.68 $837,622 - $1.11 Million	-17,750 Reduced 41.88%	24,638 $1.29 Million
Q3 2021 Nov 02, 2021	SELL	$56.91 - $67.81 $233,387 - $278,088	-4,101 Reduced 8.82%	42,388 $2.54 Million
Q2 2021 Aug 11, 2021	SELL	$64.02 - $71.72 $56,465 - $63,257	-882 Reduced 1.86%	46,489 $3.15 Million
Q1 2021 May 14, 2021	BUY	$53.26 - $68.08 $423,896 - $541,848	7,959 Added 20.19%	47,371 $3.11 Million
Q4 2020 Feb 12, 2021	BUY	$43.41 - $56.51 $12,892 - $16,783	297 Added 0.76%	39,412 $2.22 Million
Q3 2020 Nov 04, 2020	SELL	$47.43 - $60.75 $243,173 - $311,465	-5,127 Reduced 11.59%	39,115 $1.9 Million
Q2 2020 Jul 28, 2020	SELL	$43.51 - $66.59 $21,798 - $33,361	-501 Reduced 1.12%	44,242 $2.46 Million
Q1 2020 Apr 21, 2020	SELL	$32.82 - $81.13 $100,757 - $249,069	-3,070 Reduced 6.42%	44,743 $2.27 Million
Q4 2019 Feb 12, 2020	SELL	$60.96 - $77.7 $48,280 - $61,538	-792 Reduced 1.63%	47,813 $3.7 Million
Q3 2019 Nov 07, 2019	BUY	$55.78 - $68.08 $2.32 Million - $2.83 Million	41,530 Added 587.0%	48,605 $3.08 Million
Q2 2019 Aug 06, 2019	SELL	$53.69 - $65.47 $98,843 - $120,530	-1,841 Reduced 20.65%	7,075 $414,000
Q1 2019 May 06, 2019	SELL	$44.53 - $58.9 $193,082 - $255,390	-4,336 Reduced 32.72%	8,916 $506,000
Q4 2018 Feb 11, 2019	SELL	$47.64 - $71.26 $1.34 Million - $2.01 Million	-28,162 Reduced 68.0%	13,252 $657,000
Q3 2018 Nov 14, 2018	BUY	$52.03 - $71.41 $11,914 - $16,352	229 Added 0.56%	41,414 $2.94 Million
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $29,371 - $34,574	-610 Reduced 1.46%	41,185 $2.15 Million
Q1 2018 May 14, 2018	BUY	$46.03 - $61.28 $5,799 - $7,721	126 Added 0.3%	41,795 $2.18 Million
Q4 2017 Feb 14, 2018	BUY	$50.58 - $60.79 $85,429 - $102,674	1,689 Added 4.22%	41,669 $2.44 Million
Q3 2017 Nov 13, 2017	SELL	$53.54 - $68.0 $106,169 - $134,844	-1,983 Reduced 4.73%	39,980 $2.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	41,963	41,963 $3.23 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account